Bread in the basket next year6 Aug 2018 23:22
Three areas of focus, allergens with 5 to add to 53 nearly done. Food intolerance growing in USA and cd4 the 350 and 200 model.
No planned equity raise, enough cash to cover future, focus on three areas.
Lucky to get £12 million next year, £1 million profit with efficiencies made. Solid foundations to start building. I think they have made some good, quick decision from Xmas when ex CEO finished. Good overview and least there is a future.